STIMFIX Trail Lead Anchor System for Dorsal Column Stimulator Trail Leads (SECURE Study)
STIMFIX
1 other identifier
interventional
50
1 country
3
Brief Summary
This project will investigate the efficacy of a Stimfix Trail lead anchor system (StimfixTM) in patients undergoing dorsal column stimulator trial. In dorsal column stimulator trails, two leads are placed in the epidural space and various frequencies, pulse widths, and amplitudes are run to reduce pain perception. This therapy has been in use for the last 70 years and today there are about 100,000 implants done annually for various pain indications. The process of obtaining the therapy requires a trial period of seven days with percutaneous epidural leads connected to an external pulse generator (EPG). During this trial phase there has been incidence of lead migration in about 5-10% of patients resulting in trial failure. The function of StimfixTM is to standardize the lead anchoring procedure and to reduce the incidences of lead migration during the spinal cord stimulation trial phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started May 2021
Typical duration for not_applicable pain
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2021
CompletedFirst Submitted
Initial submission to the registry
December 7, 2022
CompletedFirst Posted
Study publicly available on registry
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedDecember 15, 2022
December 1, 2022
2.1 years
December 7, 2022
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To measure the Average Lead Migration in all 50 patients during the post trail follow up period
Specific Survey Data To Be Collected From Patients and Associated Time Points for achieving primary outcome: Day 0: Trial placement: Prior to StimfixTM placement on both leads - AP and Lateral Fluoroscopy Images and impedance checks for each lead Day 0: Trial placement: After each StimfixTM is placed on an individual lead check of AP and Lateral Fluoroscopy Images and impedance check Day 0: After completing the procedure, Will ask the patient to flex his body while standing and return to a prone position for imaging. Ap and lateral fluoroscopy images will be taken to check if the change in the posture is effecting the lead position Trial Day 7: Prior to removal of leads and StimfixTM device, obtain final AP and Lateral Fluoroscopy Images. Fluoroscopy measurement protocol: In all the images taken above following protocol is used to measure the change in lead migration:
7 days or Depending on the Post trial Period (Per standard of care)
Study Arms (1)
Interventional Arm
EXPERIMENTALA total of 50 subjects who are undergoing dorsal column stimulator trial will be studied and placed on the SECURE study where their trial leads will be anchored using the StimfixTM system. The trial duration will be for seven days as per standard of care.
Interventions
This is a single-arm prospective multicenter clinical study recruiting 50 subjects who are already undergoing a spinal cord stimulator trial for chronic back pain secondary to failed back surgical syndrome. Each patient who is recruited for spinal cord stimulator trial for their low back pain is informed about the traditional method of managing the leads and the trail lead anchoring system. If the patient agrees for the Stimfix trail lead anchoring clips StimfixTM, then informed consent is taken for anchoring clips usage during the spinal cord stimulator trail.
Eligibility Criteria
You may qualify if:
- years of age or older
- Must have the cognitive capacity to provide consent/permission
- Must demonstrate understanding the benefit of StimfixTM, its purpose and subject participation
You may not qualify if:
- Known allergies to adhesives and to any material to be used in this project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- STIMFIXlead
Study Sites (3)
Lake side spine & pain
Lake Havasu City, Arizona, 86403, United States
Nuvation Pain Group
Los Angeles, California, 90621, United States
Garden State Pain Control Center
Clifton, New Jersey, 07013, United States
Related Publications (1)
Green M, Narra L, Dang S, Diep J, Patel D, Lim P, Atallah J, Chakravarthy K. STIMFIX anchoring in percutaneous spinal cord stimulation trials: interim analysis of a multicenter study. Pain Manag. 2025 Aug;15(8):477-489. doi: 10.1080/17581869.2025.2527576. Epub 2025 Jul 8.
PMID: 40624980DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dipan Patel, MD
Garden State Pain Control Center
- PRINCIPAL INVESTIGATOR
Saurabh Dang, MD
Garden State Pain Control Center
- PRINCIPAL INVESTIGATOR
Phillip Lim, DO, MPH
Nuvation Pain Group
- PRINCIPAL INVESTIGATOR
Jack Diep, MD, D.ABA
Lakeside Spine and Pain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Interventional Pain Physician
Study Record Dates
First Submitted
December 7, 2022
First Posted
December 15, 2022
Study Start
May 13, 2021
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
December 15, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP